The world's first urine based colon cancer test.

Redefining Colon Cancer Detection Worldwide.

News

Revolutionary.

Colon cancer screening can be uncomfortable - we fix that while also increasing the detection accuracy.

Creating accurate, fast, & comfortable colon cancer screening for populations worldwide.

Our Aims

Seamless Integration

Clinic Readiness

Fluoroscreen is designed for smooth, uninterrupted integration into even the busiest clinic environments. With a simple injection and subsequent urine fluorescence reading, the provided kit will provide all necessary components to successful screening.

Efficient

Cost-Effective

Prevention

Proactive Screening

Neoplastic colon cells can begin to proliferate in the intestinal lumen nearly a decade before symptoms arise. Fluoroscreen increases the search capacity to a cell-surface level for optimal detection.

Public Health

Scheduling

Many more

Safe

Comfortability Prioritized

Urine samples are a convenient, routine method used in labwork worldwide in clinic settings. Fluoroscreen harnesses this powerful screening modality in the detection of colon cancer cell presence. Pairing a familiar screening procedure with a reccomened diagnostic is sure to increase compliance.

Urine - Based

Non-invasive

Potential

Build Smarter Systems

Fluoroscreen's mission does not end with colon cancer screening. This platform can have potential applicability to multiple cancer types - forever revolutionizing cancer screening worldwide.

Universal

Broad Applicability

Prevention

Proactive Screening

Neoplastic colon cells can begin to proliferate in the intestinal lumen nearly a decade before symptoms arise. Fluoroscreen increases the search capacity to a cell-surface level for optimal detection.

Public Health

Scheduling

Many more

Safe

Comfortability Prioritized

Urine samples are a convenient, routine method used in labwork worldwide in clinic settings. Fluoroscreen harnesses this powerful screening modality in the detection of colon cancer cell presence. Pairing a familiar screening procedure with a reccomened diagnostic is sure to increase compliance.

Urine - Based

Non-invasive

Potential

Build Smarter Systems

Fluoroscreen's mission does not end with colon cancer screening. This platform can have potential applicability to multiple cancer types - forever revolutionizing cancer screening worldwide.

Universal

Broad Applicability

Leadership.

The team behind Fluoroscreen.

Feature title.

Sanjana Kumar - Co-Founder

M.D Candidate Class of 2028

Feature title.

Luv Thakkar - Co-Founder

M.D Candidate Class of 2028

FAQs

We’ve Got the Answers You’re Looking For

Quick Answers to your questions about Fluoroscreen.

Is Fluoroscreen publicly availible?

What makes Fluoroscreen different?

What are the future plans of Fluoroscreen?

Where can I learn more about published data/research updates?

How can I get involved at this time?

Is Fluoroscreen publicly availible?

What makes Fluoroscreen different?

What are the future plans of Fluoroscreen?

Where can I learn more about published data/research updates?

How can I get involved at this time?

More questions? Get in touch below.

Reach out to us at anytime.

FLUOROSCREEN

Revolutionizing cancer diagnosis worldwide

Fluoroscreen LLC ©2025. Cologuard™ and Shield™ are trademarks of Exact Sciences Inc. and Guardant Health Inc. respectively. Flurosocreen is an in-development test not currently availible for public use. Fluoroscreen has not yet received FDA approval for its testing method and is not to be considered a regulated diagnostic tool at this time.


Links

Leadership

News

Socials

FLUOROSCREEN

Revolutionizing cancer diagnosis worldwide

Fluoroscreen LLC ©2025. Cologuard™ and Shield™ are trademarks of Exact Sciences Inc. and Guardant Health Inc. respectively. Flurosocreen is an in-development test not currently availible for public use. Fluoroscreen has not yet received FDA approval for its testing method and is not to be considered a regulated diagnostic tool at this time.


Links

Leadership

News

Socials